These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22114460)

  • 21. Mucopolysaccharidosis Type I.
    Kubaski F; de Oliveira Poswar F; Michelin-Tirelli K; Matte UDS; Horovitz DD; Barth AL; Baldo G; Vairo F; Giugliani R
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32188113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laronidase for the treatment of mucopolysaccharidosis type I.
    Clarke LA
    Expert Rev Endocrinol Metab; 2011 Nov; 6(6):755-768. PubMed ID: 30780865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arthropathy-like findings and a carpal tunnel syndrome as the presenting features of Scheie syndrome: Three cases from the same family.
    Gökay S; Kardaş F; Kendirci M; Sözeri B
    Turk J Pediatr; 2018; 60(3):344-347. PubMed ID: 30511553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry.
    D'Aco K; Underhill L; Rangachari L; Arn P; Cox GF; Giugliani R; Okuyama T; Wijburg F; Kaplan P
    Eur J Pediatr; 2012 Jun; 171(6):911-9. PubMed ID: 22234477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy.
    Sato Y; Fujiwara M; Kobayashi H; Yoshitake M; Hashimoto K; Oto Y; Ida H
    Mol Genet Metab Rep; 2015 Dec; 5():94-97. PubMed ID: 28649551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I.
    Brooks DA
    Expert Opin Biol Ther; 2002 Dec; 2(8):967-76. PubMed ID: 12517274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome.
    Thomas JA; Jacobs S; Kierstein J; Van Hove J
    J Inherit Metab Dis; 2006 Dec; 29(6):762. PubMed ID: 17089217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity.
    Lee-Chen GJ; Lin SP; Chen IS; Chang JH; Yang CW; Chin YW
    J Formos Med Assoc; 2002 Jun; 101(6):425-8. PubMed ID: 12189649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular Manifestations of Hurler-Scheie Syndrome: Recurrence of Host Disease in the Corneal Transplant.
    Kölkedi Z; Csutak A; Szalai E
    Mol Syndromol; 2023 Feb; 14(1):44-50. PubMed ID: 36777710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications.
    Peña-Gomar I; Jiménez-Mariscal JL; Cerón M; Rosas-Trigueros J; Reyes-López CA
    Protein J; 2021 Feb; 40(1):68-77. PubMed ID: 33389473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha-L-iduronidase activity.
    Lee-Chen GJ; Lin SP; Tang YF; Chin YW
    Clin Genet; 1999 Jul; 56(1):66-70. PubMed ID: 10466419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.
    Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J
    Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome.
    Chkioua L; Boudabous H; Jaballi I; Grissa O; Turkia HB; Tebib N; Laradi S
    Diagn Pathol; 2018 May; 13(1):35. PubMed ID: 29843745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
    Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
    Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical discrimination of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V
    Clin Sci (Lond); 1979 Sep; 57(3):265-72. PubMed ID: 38945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK.
    Moore D; Connock MJ; Wraith E; Lavery C
    Orphanet J Rare Dis; 2008 Sep; 3():24. PubMed ID: 18796143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families.
    Sun L; Li C; Song X; Zheng N; Zhang H; Dong G
    Genet Mol Biol; 2011 Apr; 34(2):195-200. PubMed ID: 21734815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings.
    Winters PR; Harrod MJ; Molenich-Heetred SA; Kirkpatrick J; Rosenberg RN
    Neurology; 1976 Nov; 26(11):1003-7. PubMed ID: 824566
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.